Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

DBV Technologies (DBVT)

DBV Technologies SA
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DBVT
DateTimeSourceHeadlineSymbolCompany
05/06/202421:30GlobeNewswire Inc.DBV Technologies to Participate in the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:DBVTDBV Technologies SA
04/06/202421:30GlobeNewswire Inc.Information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2024NASDAQ:DBVTDBV Technologies SA
31/05/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DBVTDBV Technologies SA
31/05/202414:51GlobeNewswire Inc.DBV Technologies Announces Plan to Implement ADS Ratio ChangeNASDAQ:DBVTDBV Technologies SA
30/05/202421:30GlobeNewswire Inc.DBV Technologies to Participate in Upcoming EAACI 2024 CongressNASDAQ:DBVTDBV Technologies SA
29/05/202421:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DBVTDBV Technologies SA
17/05/202421:38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DBVTDBV Technologies SA
17/05/202421:30GlobeNewswire Inc.DBV Technologies Announces Plan to Implement ADS Ratio ChangeNASDAQ:DBVTDBV Technologies SA
16/05/202421:30GlobeNewswire Inc.DBV Technologies Announces Results of its 2024 Combined General MeetingNASDAQ:DBVTDBV Technologies SA
16/05/202421:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DBVTDBV Technologies SA
09/05/202421:30GlobeNewswire Inc.DBV Technologies to Participate in Upcoming Investor ConferencesNASDAQ:DBVTDBV Technologies SA
07/05/202421:30GlobeNewswire Inc.DBV Technologies Reports First Quarter 2024 Financial Results and Business UpdateNASDAQ:DBVTDBV Technologies SA
25/04/202421:30GlobeNewswire Inc.Combined General Meeting of May 16, 2024NASDAQ:DBVTDBV Technologies SA
04/04/202421:43GlobeNewswire Inc.Information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2024NASDAQ:DBVTDBV Technologies SA
08/03/202414:33GlobeNewswire Inc.DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration DocumentNASDAQ:DBVTDBV Technologies SA
07/03/202421:30GlobeNewswire Inc.DBV Technologies Reports Full Year 2023 Financial Results and Business UpdateNASDAQ:DBVTDBV Technologies SA
04/03/202421:30GlobeNewswire Inc.DBV Technologies to Report Full Year 2023 Financial Results and Business Update on March 7, 2024NASDAQ:DBVTDBV Technologies SA
20/02/202421:30GlobeNewswire Inc.DBV Technologies to Participate in Upcoming AAAAI 2024 CongressNASDAQ:DBVTDBV Technologies SA
14/02/202421:06Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:DBVTDBV Technologies SA
16/01/202421:30GlobeNewswire Inc.Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHFNASDAQ:DBVTDBV Technologies SA
22/12/202311:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DBVTDBV Technologies SA
04/12/202321:30GlobeNewswire Inc.Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2023  NASDAQ:DBVTDBV Technologies SA
09/11/202321:30GlobeNewswire Inc.DBV Technologies Announces 2-Year Results from Ongoing Phase 3 Open-Label Extension to the EPITOPE Trial (EPOPEX) of Viaskinâ„¢ Peanut in ToddlersNASDAQ:DBVTDBV Technologies SA
06/11/202321:30GlobeNewswire Inc.Monthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2023NASDAQ:DBVTDBV Technologies SA
02/11/202320:30GlobeNewswire Inc.DBV Technologies to Present New Data at ACAAI 2023NASDAQ:DBVTDBV Technologies SA
02/11/202312:00Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:DBVTDBV Technologies SA
31/10/202322:48Dow Jones NewsDBV Tech Gets Requested Feedback from FDA on Comfort Safety StudiesNASDAQ:DBVTDBV Technologies SA
31/10/202320:30GlobeNewswire Inc.DBV Technologies Receives Requested Feedback from FDA on Protocol Design Elements for COMFORT Safety Studies and Reports Third Quarter 2023 Financial ResultsNASDAQ:DBVTDBV Technologies SA
27/10/202321:30GlobeNewswire Inc.DBV Technologies to Report Third Quarter 2023 Financial Results and Business UpdateNASDAQ:DBVTDBV Technologies SA
16/10/202307:00GlobeNewswire Inc.DBV Technologies Announces Appointment of Virginie Boucinha as Chief Financial OfficerNASDAQ:DBVTDBV Technologies SA
 Showing the most relevant articles for your search:NASDAQ:DBVT